Compounds > amifostine anhydrous

amifostine anhydrous and org 2766

amifostine anhydrous has been researched along with org 2766 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (71.43)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gispen, W; Hamers, F; Neijt, J1
De Gregorio, MW; Gandara, DR; Perez, EA; Weibe, V1
Tognella, S1
Lewis, C1
Lewis, C; Links, M1
Balm, AJ; Beijnen, JH; Schellens, JH; van den Berg, JH1
Albers, J; Cavaletti, G; Chaudhry, V; Donehower, R1

Reviews

6 review(s) available for amifostine anhydrous and org 2766

ArticleYear
Cisplatin chemoprotection and rescue: pharmacologic modulation of toxicity.
    Seminars in oncology, 1991, Volume: 18, Issue:1 Suppl 3

    Topics: Adrenocorticotropic Hormone; Amifostine; Anticonvulsants; Cisplatin; Ditiocarb; Humans; Inactivation, Metabolic; Kidney Diseases; Neoplasms; Peptide Fragments

1991
Pharmacological interventions to reduce platinum-induced toxicity.
    Cancer treatment reviews, 1990, Volume: 17, Issue:2-3

    Topics: Adrenocorticotropic Hormone; Amifostine; Cisplatin; Ditiocarb; Fluid Therapy; Glutathione; Hematologic Diseases; Humans; Kidney Diseases; Nervous System Diseases; Peptide Fragments; Thiosulfates

1990
A review of the use of chemoprotectants in cancer chemotherapy.
    Drug safety, 1994, Volume: 11, Issue:3

    Topics: Adrenocorticotropic Hormone; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Drug Interactions; Humans; Mesna; Neoplasms; Peptide Fragments; Razoxane

1994
Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy.
    Drugs, 1999, Volume: 57, Issue:3

    Topics: Adrenocorticotropic Hormone; Amifostine; Animals; Antineoplastic Agents; Clinical Trials as Topic; Female; Glutathione; Humans; Mesna; Peptide Fragments; Protective Agents; Radiation-Protective Agents; Razoxane

1999
Future opportunities in preventing cisplatin induced ototoxicity.
    Cancer treatment reviews, 2006, Volume: 32, Issue:5

    Topics: Adrenocorticotropic Hormone; Amifostine; Animals; Antineoplastic Agents; Cisplatin; Hearing Loss; Humans; Peptide Fragments; Protective Agents

2006
Interventions for preventing neuropathy caused by cisplatin and related compounds.
    The Cochrane database of systematic reviews, 2007, Jan-24, Issue:1

    Topics: Adrenocorticotropic Hormone; Amifostine; Antineoplastic Agents; Cisplatin; Ditiocarb; Glutathione; Humans; Neuroprotective Agents; Peptide Fragments; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic; Vitamin E

2007

Other Studies

1 other study(ies) available for amifostine anhydrous and org 2766

ArticleYear
Protection of cisplatin-induced neuropathy: recent developments.
    Pathologie-biologie, 1992, Volume: 39, Issue:9

    Topics: Adrenocorticotropic Hormone; Amifostine; Anticonvulsants; Cisplatin; Female; Glutathione; Humans; Nervous System Diseases; Ovarian Neoplasms; Peptide Fragments

1992